Navigation Links
Ipilimumab in advanced melanoma: added benefit for non-pretreated patients not proven
Date:6/12/2014

ed in favour of ipilimumab, and not all relevant confounders were considered in the analysis.

Subsequent assessment in two addenda

In addition, the manufacturer had presented data on the comparison of ipilimumab with vemurafenib in its dossier. IQWiG did not examine these data in its dossier assessment because the G-BA had not specified vemurafenib as an appropriate comparator therapy at first. In March 2014, shortly before completion of the IQWiG dossier assessment, the G-BA commissioned the Institute to also assess the potential added benefit versus vemurafenib. Moreover, the manufacturer submitted corrected and updated data analyses in the commenting procedure on the dossier assessment in April 2014. Following the G-BA's commission, IQWiG now assessed these data in a second addendum.

Indirect comparison not interpretable

As so far there are no studies that directly compare ipilimumab with vemurafenib, the manufacturer used an indirect comparison, in which dacarbazine was used as a so-called common comparator. In this indirect comparison, on the one hand it used data from the BRIM-3 study, a randomized phase 3 study comparing vemurafenib with dacarbazine.

For the second side of the indirect comparison, the manufacturer did not use a direct comparison between ipilimumab and dacarbazine. Instead, it used the unadjusted indirect comparison again, which it had already used for examining the added benefit in comparison with dacarbazine. Hence the indirect comparison between ipilimumab and vemurafenib is also subject to great uncertainties. No conclusions on added benefit can be derived from this.

General weakness of analysis not resolved

In the second addendum, the Institute examined the corrected analyses subsequently submitted by the manufacturer. This correction reduced the exclusion of patients, but, in the outcome "overall survival", the exclusion w
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Marker may predict response to ipilimumab in advanced melanoma
2. Study: Ipilimumab Shows Durable Responses But Low Overall Response Rate In Patients With Unresectable Or Metastatic Mucosal Melanoma
3. Considerable added benefit of ipilimumab in advanced melanoma
4. Advanced breast cancer: Benefits of Trastuzumab (Herceptin) outweigh the risk of harm
5. Early palliative support services help those caring for patients with advanced cancer
6. UIC conducts phase I drug study for advanced pancreatic cancer
7. Long-term results encouraging for combination immunotherapy for advanced melanoma
8. Immune therapy for advanced bladder cancer yields promising results
9. Better sleep predicts longer survival time for women with advanced breast cancer
10. Drinking poses greater risk for advanced liver disease in HIV/hep C patients
11. Palliation is rarely a topic in studies on advanced cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... ... products, is helping families get ready for Independence Day celebrations with new takes ... easy and versatile options are perfect for any summertime get together. , “Celebrating ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... their big summer sale. Customers purchasing two or more Bunion Booties directly ... , Bunion Bootie temporarily corrects misaligned toes and its ultra thin ...
(Date:7/1/2015)... ... ... wasn’t always a steadfast supporter of plastic surgery. But just as her career in ... terrible car accident years ago left her injured and in need of reconstructive surgery ... if I Do?): Answers to All Your Questions about Plastic Surgery” (published by Archway Publishing), ...
(Date:7/1/2015)... ... 01, 2015 , ... B. E. Smith, the only full-service ... a national chief executive officer recruitment for Citizens Medical Center in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... ... 2015 , ... Who doesn’t want a life filled with thriving positivity and ... between work and life, and positive friendships and relationships? , Dr. Marsha W. ... Wellbeing in Doctors. , With a focus on solving the epidemic of ill-being in ...
Breaking Medicine News(10 mins):Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2
... genetics-based explanation for the causes of anorexia nervosa were ... illness than those given a sociocultural explanation, a University ... This is a potentially important finding, said first author ... of information about the biological and genetic underpinnings of ...
... /Xinhua-PRNewswire/ -- Sundia MediTech,(Shanghai) Company recently announced a welcome ... Zhu and Dr. Shu Gao. Dr. Zhu is appointed ... as the Vice,President in charge of Chemical Synthesis business., ... his college,education in chemistry in Nanjing University in China. ...
... will release its fourth quarter and year-end 2007 financial ... The earnings,release will be available on the PPD Web ... On Thursday, February 7, 2008, at 9 a.m. EST, ... to discuss financial results and the,overall business environment. A ...
... CDC Prepares to Release Alarming New HIV Rates; ... Jan. 10 AIDS Healthcare,Foundation (AHF) today urged ... million of proposed budget cuts in AIDS services,that ... services for,Californians living with HIV/AIDS as he seeks ...
... that Program Integrity will,be Needlessly Compromised in the Interim, ... today applauded the Centers for Medicare and Medicaid,Services (CMS) ... need to be accredited, but expressed concern that it ... be fully implemented. The PMC,however, further commends CMS for ...
... for when antiviral drugs fail , , THURSDAY, Jan. 10 ... human proteins that help HIV propagate, creating hope for ... , Using a technique called RNA interference to screen ... according to the study published online Jan. 10 in ...
Cached Medicine News:Health News:People with anorexia less likely to be blamed when biology, genetics explained 2Health News:People with anorexia less likely to be blamed when biology, genetics explained 3Health News:CRO Company Sundia Welcomes New Members to Its Executive Team 2Health News:PPD Announces Fourth Quarter and Year-End 2007 Earnings Release, Webcast and Conference Call 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 3Health News:Mandatory Accreditation Delayed Until September 2009 2Health News:New Proteins That Help HIV Grow Identified 2
(Date:7/1/2015)... , July 1, 2015 Radiant ... Stationary Oxygen Concentrators Market Shares, Strategy, and ... to achieve continuing growth as the aging population worldwide ... other respiratory conditions where oxygen is able to improve ... Portable devices have become affordable and support a mobile ...
(Date:7/1/2015)... -- The global mHealth market ... million by 2020, according to a new study by ... remain the dominant and fastest growing market segment, with ... an estimated CAGR of 49.7% from 2014 to 2020. ... Browse full research report with TOC on ...
(Date:6/30/2015)... 2015  The MEDevice San Diego Conference, returning for ... dedicated to bringing medtech professionals together for panel discussions ... the industry today. This year,s conference will highlight brand ... facing today,s medtech professional in a fun, informal environment. ... MEDevice San Diego, please visit: MEDeviceSD.com. ...
Breaking Medicine Technology:Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
the LabOne Healthcare Group markets laboratory testing to physicians, patients, managed care companies, self-insured employers, wellness companies and hospitals....
Mayo Medical Laboratories (MML) is the diagnostic reference laboratory for Mayo Clinic. MML specializes in esoteric laboratory testing for health care organizations throughout the United States and a...
Medicine Products: